Bivatuzumab mertansine
Encyclopedia
Bivatuzumab mertansine is a combination of bivatuzumab
, a humanize
d monoclonal antibody, and mertansine
, a cytotoxic agent. It is designed for the treatment of squamous cell carcinoma
.
Bivatuzumab
Bivatuzumab is a humanized monoclonal antibody against CD44 v6.It is officially described as "immunoglobulin G1 , disulfide with human-mouse monoclonal BIWA4 κ-chain, dimer"...
, a humanize
Humanize
Humanize may refer to:*Humanize a 2001 album by the British jazz/funk band Big Boss Man*Humanized antibody, a type of monoclonal antibody...
d monoclonal antibody, and mertansine
Mertansine
Mertansine is a cytotoxic agent also known as DM1. It is a maytansinoid .Its patent rights are owned by ImmunoGen Inc.- Uses :...
, a cytotoxic agent. It is designed for the treatment of squamous cell carcinoma
Squamous cell carcinoma
Squamous cell carcinoma , occasionally rendered as "squamous-cell carcinoma", is a histologically distinct form of cancer. It arises from the uncontrolled multiplication of malignant cells deriving from epithelium, or showing particular cytological or tissue architectural characteristics of...
.